Can stress shorten life in brain cancer? new study investigates
NCT ID NCT05431348
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at whether stress and exercise levels influence survival and quality of life in 42 people with glioblastoma, a severe brain cancer. Participants wore a smartwatch to track heart rate, sleep, and activity, and filled out questionnaires on stress and fatigue. The goal was to see if stress markers like cortisol and heart rate are linked to how long patients live after chemoradiation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If stress is confirmed as a key factor, future treatments might include stress-reduction programs to improve outcomes.
What could go wrong
This is a small, observational study with only 42 participants. It cannot prove cause and effect, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA (GBM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Maastricht Radiation Oncology (Maastro)
Maastricht, Limburg, 6229ET, Netherlands
-
Verbeeten Insitute Tilburg
Tilburg, Netherlands